Atlas Trials

Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer

Clinical trial NCT00921310 · TERMINATED

Trial details

NCT number
NCT00921310
Sponsor
Washington University School of Medicine
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Carcinoma, Non-Small-Cell Lung
Start date
2009-09-01
Primary completion
2013-01-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.